Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (ISRCTN99170029) titled 'Predictors of disease activity in multiple sclerosis' on Oct. 7.
Study Type: Observational
Study Design:
2-year prospective observational multi-centred observational study (Other)
Primary Sponsor: NHS Lothian
Condition:
Development of "disease activity" prediction tools based on next-generation biomarkers in people with multiple sclerosis to inform prospective decisions about the personalised risk/benefit relationship of available treatments
Nervous System Diseases
Intervention:
Study visits will be fully integrated into routine clinical care with data collected from hospital electronic records on treatment...